Home > Business Cases > Rationale of action of new compounds in Nutraceuticals
Rationale of action of new compounds in Nutraceuticals
-
A nutraceuticals company specialized in high-protein diets requests Anaxomics to provide scientific background to support their claims in using their diet for diabetic patients.
-
The diet is based on high-protein-low-carbon functional food, so that the patient is maintained close to Ketosis status.
-
Anaxomics creates the protein map related with ketosis, and establishes the relationship between the ketosis and diabetes map (among other conditions).
-
Anaxomics generates new hypothesis for the nutraceuticals company to pursue their quest of scientific claims for their product.
-
Anaxomics delivers 2 scientific articles and several communications to congresses.
As a result of our strategy, a number of research articles have been published in relevant publications, like for example:
NutraFoods 2010, 9: 31
Jordi Naval, Judith Farrés
Systems Biology footprint on the nutraceuticals and cosmetics arena
"Systems Biology, a new and validated integrative technology, finds many uses in the fields of cosmetics and nutraceuticals, accelerating the design of new products, and providing scientific support for health claims"
Nutr Metab, 2010, 7: 88
Judith Farrés, Albert Pujol, Mireia Coma, Jose Luis Ruiz, Jordi Naval, Josè Manuel Mas, Agustì Molins, Joan Fondevila, Patrick Aloy
Revealing the molecular relationship between type 2 diabetes and the metabolic changes induced by a very-low-carbohydrate low-fat ketogenic diet
"A strong relationship between the insulin resistance pathway and the ketosis main pathway was identified, providing a possible explanation for the improvement observed in clinical trials"
Please, contact us here to request more information.
